HONG KONG , March 6, 2024 /PRNewswire/ -- Akeso Inc. ("Akeso", 9926. HK) announced the enrollment of the first patient in the registrational Phase III clinical study comparing Cadonilimab ( PD-1/CTLA-4 bispecific antibody) combined ...
Data to showcase PROphet® platform's machine learning models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy BINYAMINA, Israel and CARY, N.C. , ...
More than 150 advocates joined DDF in Washington, DC ., urging Congress members to fund more research for stomach cancer. WASHINGTON , March 5, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer celebrated a ...
ROCKVILLE, Md. and SUZHOU, China , March 5, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the ...
PLEASANTON, Calif. , March 4, 2024 /PRNewswire/ -- DiaCarta proudly announced that the Oncuria® Bladder Cancer Tests, developed by Nonagen Bioscience and validated by DiaCarta as a Lab Developed Test (LDT), at its CAP-accredited and ...
SEOUL, South Korea , Feb. 29, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on Feb 27 that the US FDA had granted an orphan drug designation for pancreatic cancer for SNB-101 (API: SN-38), a new polymer ...
BERLIN , Feb. 29, 2024 /PRNewswire/ -- Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, is pleased to announce that it has ...
New collaboration helps address barriers to clinical trials participation, expands resources to patients and caregivers CHESTER, N.J. , Feb. 28, 2024 /PRNewswire-PRWeb/ -- Cancer Hope Network and Lazarex Cancer Foundation announced ...
Using RNA sequencing and spatial transcriptomics, the roles of PKM gene and EPHA2 pathway in the development of HNSCC were discovered. BUSAN, South Korea , Feb. 28, 2024 /PRNewswire/ -- Head and neck squamous cell carcinoma (HNSCC) is ...
HONG KONG , Feb. 28, 2024 /PRNewswire/ -- Akeso (9926.HK) announced that the results of a phase II clinical trial for PD-1/CTLA-4 bispecific antibody(cadonilimab)combined with standard treatment (chemotherapy +/- bevacizumab) as ...
Ethylene oxide, known for its carcinogenic properties, heightens the risk of breast cancer and causes DNA damage, affecting brain and nervous system function in humans. Recent findings reveal its presence in four products from two major spice brands ...
US researchers have pioneered a novel immunotherapy approach utilizing cytokine proteins as a promising treatment, precisely targeting tumors while sparing healthy cells from harm...
During a recent 2024 Annual meeting of the American Association for Cancer Research (AACR), promising data from a Phase II trial were presented. The outcome of the trial proved the effectiveness of the combination treatment involving Immunogen's ...
India shoulders a substantial burden of oral cancers , accounting for approximately 30% of all global cases. April is Oral Cancer Awareness Month. Also known as mouth cancer, the disease is the most common form of head and neck ...
Groundbreaking research introduces drug-loaded 3D printed films that could revolutionize cancer treatments. These innovative films, containing tailored doses of anti-cancer drugs 5-fluorouracil (5FU) and cisplatin (Cis), not only eliminate over 80% ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers